Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17951-18000 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03273413
Statin Therapy in Patients With Early Stage ADPKD
PHASE4
Active, not recruiting
150 participants
Started: Aug 31, 2017 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT03243539
Implementation of Neuro Lung Protective Ventilation
NA
Active, not recruiting
728 participants
Started: Aug 31, 2017 · Completed: Dec 31, 2024
6 conditions
1 sponsor
1 location
NCT03239626
Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer
NA
Active, not recruiting
120 participants
Started: Aug 31, 2017 · Completed: Apr 28, 2025
4 conditions
1 sponsor
1 location
NCT03922932
WF and PR OCTA in Diabetic Retinopathy
N/A
Active, not recruiting
290 participants
Started: Aug 30, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03340376
Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer
PHASE2
Active, not recruiting
48 participants
Started: Aug 30, 2017 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT03251495
Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
PHASE2
Active, not recruiting
34 participants
Started: Aug 29, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02931240
BioVentrix Revivent TC™ System Clinical Study
NA
Active, not recruiting
126 participants
Started: Aug 29, 2017 · Completed: Jun 30, 2027
1 condition
1 sponsor
30 locations
NCT03364621
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy
N/A
Active, not recruiting
17 participants
Started: Aug 29, 2017 · Completed: Jun 29, 2026
3 conditions
3 sponsors
2 locations
NCT05271370
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
PHASE2/PHASE3
Active, not recruiting
56 participants
Started: Aug 29, 2017 · Completed: Apr 10, 2023
1 condition
1 sponsor
1 location
NCT03312972
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy
NA
Active, not recruiting
50 participants
Started: Aug 28, 2017 · Completed: Jul 31, 2026
1 condition
1 sponsor
2 locations
NCT03269422
Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)
PHASE1
Active, not recruiting
35 participants
Started: Aug 28, 2017 · Completed: Aug 28, 2026
1 condition
1 sponsor
7 locations
NCT03093493
Genetics of Ehlers-Danlos Syndrome
N/A
Active, not recruiting
334 participants
Started: Aug 25, 2017 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT02890160
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
NA
Active, not recruiting
430 participants
Started: Aug 24, 2017 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT03047213
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
PHASE2
Active, not recruiting
17 participants
Started: Aug 24, 2017 · Completed: Nov 11, 2025
6 conditions
1 sponsor
20 locations
NCT03017326
Paediatric Hepatic International Tumour Trial
PHASE3
Active, not recruiting
450 participants
Started: Aug 24, 2017 · Completed: Aug 1, 2027
2 conditions
23 sponsors
32 locations
NCT03213704
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
PHASE2
Active, not recruiting
9 participants
Started: Aug 23, 2017 · Completed: Oct 8, 2025
33 conditions
1 sponsor
124 locations
NCT03246347
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
PHASE2
Active, not recruiting
40 participants
Started: Aug 23, 2017 · Completed: Mar 31, 2028
2 conditions
3 sponsors
1 location
NCT03238326
Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
PHASE3
Active, not recruiting
295 participants
Started: Aug 23, 2017 · Completed: Aug 5, 2025
1 condition
2 sponsors
57 locations
NCT03130777
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
NA
Active, not recruiting
86 participants
Started: Aug 22, 2017 · Completed: Jun 30, 2032
5 conditions
1 sponsor
14 locations
NCT03679026
"The Motoric Cognitive Risk Syndrome in the Canadian Population"
N/A
Active, not recruiting
1,461 participants
Started: Aug 22, 2017 · Completed: Dec 21, 2024
3 conditions
1 sponsor
1 location
NCT02889874
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NA
Active, not recruiting
1,167 participants
Started: Aug 21, 2017 · Completed: Apr 30, 2028
1 condition
3 sponsors
68 locations
NCT04024943
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
N/A
Active, not recruiting
1,092 participants
Started: Aug 21, 2017 · Completed: Jan 31, 2028
1 condition
1 sponsor
115 locations
NCT03009240
Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia
PHASE1
Active, not recruiting
30 participants
Started: Aug 21, 2017 · Completed: Mar 30, 2026
6 conditions
2 sponsors
1 location
NCT03250975
Incidence of Acute Laryngeal Injury Following Endotracheal Intubation
PHASE1/PHASE2
Active, not recruiting
64 participants
Started: Aug 19, 2017 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT03207672
Study of E7389 Liposomal Formulation in Participants With Solid Tumor
PHASE1
Active, not recruiting
140 participants
Started: Aug 18, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
12 locations
NCT03008408
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
PHASE2
Active, not recruiting
90 participants
Started: Aug 18, 2017 · Completed: Aug 31, 2028
13 conditions
1 sponsor
2 locations
NCT03396640
Medial Unicondylar Knee Arthroplasty vs Total Knee Arthroplasty
NA
Active, not recruiting
350 participants
Started: Aug 17, 2017 · Completed: Oct 16, 2041
1 condition
9 sponsors
11 locations
NCT03190954
Brain Dopaminergic Signaling in Opioid Use Disorders
EARLY_PHASE1
Active, not recruiting
153 participants
Started: Aug 17, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03104842
Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
PHASE2
Active, not recruiting
246 participants
Started: Aug 15, 2017 · Completed: Sep 30, 2026
1 condition
1 sponsor
17 locations
NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
PHASE3
Active, not recruiting
325 participants
Started: Aug 15, 2017 · Completed: Jun 30, 2025
4 conditions
1 sponsor
23 locations
NCT03179553
Heart Beat Variability in Neonatal Encephalopathy
N/A
Active, not recruiting
210 participants
Started: Aug 15, 2017 · Completed: Nov 28, 2025
3 conditions
1 sponsor
5 locations
NCT02932501
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
N/A
Active, not recruiting
518 participants
Started: Aug 14, 2017 · Completed: Apr 30, 2024
2 conditions
2 sponsors
14 locations
NCT02888743
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
110 participants
Started: Aug 14, 2017 · Completed: Jan 2, 2026
6 conditions
1 sponsor
42 locations
NCT03202316
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer
PHASE2
Active, not recruiting
37 participants
Started: Aug 11, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03146078
Rate of Progression in USH2A-related Retinal Degeneration
N/A
Active, not recruiting
127 participants
Started: Aug 11, 2017 · Completed: Dec 31, 2029
2 conditions
2 sponsors
16 locations
NCT02893917
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
PHASE2
Active, not recruiting
90 participants
Started: Aug 11, 2017 · Completed: Jun 18, 2026
6 conditions
1 sponsor
16 locations
NCT03719339
VIRTUUS Children's Study
N/A
Active, not recruiting
445 participants
Started: Aug 10, 2017 · Completed: Aug 31, 2025
7 conditions
2 sponsors
13 locations
NCT03089905
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
PHASE3
Active, not recruiting
450 participants
Started: Aug 10, 2017 · Completed: Jun 30, 2026
3 conditions
13 sponsors
21 locations
NCT03192397
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
PHASE1/PHASE2
Active, not recruiting
35 participants
Started: Aug 9, 2017 · Completed: May 21, 2027
13 conditions
1 sponsor
1 location
NCT02295059
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
NA
Active, not recruiting
80 participants
Started: Aug 9, 2017 · Completed: Jun 22, 2026
1 condition
2 sponsors
2 locations
NCT03226158
Next Generation Pathogen Sequencing for Prediction of Adverse Events
N/A
Active, not recruiting
160 participants
Started: Aug 9, 2017 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT03007147
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
PHASE3
Active, not recruiting
475 participants
Started: Aug 8, 2017 · Completed: Sep 30, 2027
4 conditions
3 sponsors
226 locations
NCT03114527
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
PHASE2
Active, not recruiting
48 participants
Started: Aug 8, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT03383445
Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial
NA
Active, not recruiting
300 participants
Started: Aug 8, 2017 · Completed: May 30, 2024
3 conditions
1 sponsor
1 location
NCT03244995
Mind-Body Intervention in Glioma Couples
NA
Active, not recruiting
74 participants
Started: Aug 6, 2017 · Completed: Dec 31, 2025
6 conditions
2 sponsors
1 location
NCT03160079
Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Aug 4, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
4 locations
NCT03220477
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
PHASE1
Active, not recruiting
28 participants
Started: Aug 4, 2017 · Completed: Jul 31, 2026
1 condition
6 sponsors
3 locations
NCT03293173
Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis
PHASE2
Active, not recruiting
120 participants
Started: Aug 4, 2017 · Completed: Dec 31, 2024
1 condition
3 sponsors
16 locations
NCT03245892
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
PHASE1
Active, not recruiting
40 participants
Started: Aug 4, 2017 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT03162627
Selumetinib and Olaparib in Solid Tumors
PHASE1
Active, not recruiting
90 participants
Started: Aug 4, 2017 · Completed: Aug 30, 2026
5 conditions
2 sponsors
1 location
Previous
1
More pages
357
358
359
360
361
362
363
More pages
431
Next